You-Jie Li
Overview
Explore the profile of You-Jie Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
618
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu R, Zhang H, Xin J, Xie S, Jiao F, Li Y, et al.
Thorac Cancer
. 2024 Aug;
15(27):1929-1945.
PMID: 39113208
Background: The aim of the present study was to investigate the function of novel circular RNA hsa_circ_0036683 (circ-36683) in non-small cell lung cancer (NSCLC). Methods: RNA sequencing was used to...
2.
Zhou Y, Yu L, Wang X, Li Y, Xu K, Li X, et al.
Biochem Pharmacol
. 2024 Jul;
227:116444.
PMID: 39038551
Regenerating family protein 2 (Reg2) is a trophic factor which stimulates β-cell replication and resists islet destruction. However, Reg2 also serves as an islet autoantigen, which makes it complicated to...
3.
Zhang M, Fang L, Guo Y, Wang Q, Li Y, Sun H, et al.
Int J Nanomedicine
. 2024 Apr;
19:3387-3404.
PMID: 38617801
Cancer immunotherapy has emerged as a novel therapeutic approach against tumors, with immune checkpoint inhibitors (ICIs) making significant clinical practice. The traditional ICIs, PD-1 and PD-L1, augment the cytotoxic function...
4.
Shen H, Peng J, Wang R, Wang P, Zhang J, Sun H, et al.
Int J Nanomedicine
. 2024 Mar;
19:2755-2772.
PMID: 38525008
Purpose: The drug resistance and low response rates of immunotherapy limit its application. This study aimed to construct a new nanoparticle (CaCO-polydopamine-polyethylenimine, CPP) to effectively deliver interleukin-12 (IL-12) and suppress...
5.
Zhao W, Hu J, Hao R, Zhang Q, Guo J, Li Y, et al.
Oncol Rep
. 2024 Mar;
51(5).
PMID: 38456515
After the publication of the article, an interested reader drew to the authors' attention that, in the western blots shown in Fig. 5C and D, a pair of data panels...
6.
Liang D, Li Y, Zhang J, Shen H, Wu C, Xie N, et al.
Commun Biol
. 2024 Feb;
7(1):215.
PMID: 38383737
Blocking immune checkpoint CD47/SIRPα is a useful strategy to engineer macrophages for cancer immunotherapy. However, the roles of CD47-related noncoding RNA in regulating macrophage phagocytosis for lung cancer therapy remain...
7.
Yi Y, Jia X, Wang J, Li Y, Wang H, Xie S
Int J Mol Med
. 2023 Oct;
52(6).
PMID: 37830154
Following the publication of the above article, an interested reader drew to the authors' attention that, in Fig. 2 on p. 1408, the microscopic images shown for the light scope...
8.
Liang Y, Wang P, Liu Z, Sun H, Wang Q, Sun G, et al.
Int J Nanomedicine
. 2023 Aug;
18:4381-4402.
PMID: 37551273
Introduction: As the special modality of cell death, immunogenic cell death (ICD) could activate immune response. Phototherapy in combination with chemotherapy (CT) is a particularly efficient tumor ICD inducing method...
9.
Zhang Y, Wang R, Liu R, Xie S, Jiao F, Li Y, et al.
Thorac Cancer
. 2023 Feb;
14(10):913-928.
PMID: 36808485
Background: The present study aimed to investigate the function of miR-3529-3p in lung adenocarcinoma and MnO -SiO -APTES (MSA) as a promising multifunctional delivery agent for lung adenocarcinoma therapy. Methods:...
10.
Liang Y, Wang P, Li Y, Liu Z, Wang R, Sun G, et al.
Int J Pharm
. 2022 Dec;
631:122488.
PMID: 36521638
Reduced drug uptake and elevated drug efflux are two major mechanisms in cancer multidrug resistance (MDR). In the present study, a new multistage O-producing liposome with NAG/R8-dual-ligand and stimuli-responsive dePEGylation...